Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07468656) titled 'SCLC Tarlatamab Blood Collection' on March 9.

Study Type: Observational

Primary Sponsor: Duke University

Condition: Small-cell Lung Cancer

Recruitment Status: Not recruiting

Date of First Enrollment: May 2026

Target Sample Size: 25

To know more, visit https://clinicaltrials.gov/study/NCT07468656

Disclaimer: Curated by HT Syndication....